Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patientsSilvia Ferrucci, Maria Esposito, Martina Maurelli et al.|Clinical and Experimental Dermatology|2024Cited by 15
Effectiveness and Safety of Upadacitinib for Adolescents with Atopic Dermatitis in a Real-World SettingCataldo Patruno, Maddalena Napolitano, Giuseppe Lauletta et al.|Clinical Drug Investigation|2024Cited by 15
Five‐year drug survival of dupilumab in atopic dermatitis: Italian landscape <scp>AD</scp> real‐world studyLuigi Gargiulo, Benedetta Tirone, Silvia Mariel Ferrucci et al.|Journal of the European Academy of Dermatology and Venereology|2025Cited by 9
Efficacy and drug survival of tralokinumab in patients with severe atopic dermatitis: an 18-month multicentre studyFrancesca Barei, Silvia Mariel Ferrucci, Paolo Calzari et al.|Clinical and Experimental Dermatology|2025Cited by 5